Victory Capital Management Portfolio holdings
AUM
$155B
1-Year Return
20.6%
This Quarter Return
+7.52%
1 Year Return
+20.6%
3 Year Return
+77.5%
5 Year Return
+161.59%
10 Year Return
+412.71%
AUM
$104B
AUM Growth
+$6.58B
(+6.7%)
Cap. Flow
-$901M
Cap. Flow
% of AUM
-0.86%
Top 10 Holdings %
Top 10 Hldgs %
10.66%
Holding
2,870
New
128
Increased
1,119
Reduced
1,403
Closed
129
Top Buys
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.31B |
| 2 |
iShares Core MSCI EAFE ETF
IEFA
|
+$733M |
| 3 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$371M |
| 4 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$336M |
| 5 |
VF Corp
VFC
|
+$271M |
Top Sells
| 1 |
Darden Restaurants
DRI
|
+$314M |
| 2 |
TCF
TCF Financial Corporation Common Stock
TCF
|
+$245M |
| 3 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$205M |
| 4 |
Healthcare Realty
HR
|
+$159M |
| 5 |
Aflac
AFL
|
+$155M |
Sector Composition
| 1 | Technology | 17.57% |
| 2 | Industrials | 13.84% |
| 3 | Financials | 12.11% |
| 4 | Consumer Discretionary | 11.36% |
| 5 | Healthcare | 9.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2551
SFL Corp
SFL
$1.09B
| $124K | ﹤0.01% |
16,151
-500
| -3% | -$3.84K |
|
2552
Vaalco Energy
EGY
$409M
| $121K | ﹤0.01% |
37,160
-42,360
| -53% | -$138K |
|
|
BWAY
2553
Brainsway
BWAY
$299M
| $119K | ﹤0.01% |
11,679
| – | – |
|
2554
Carisma Therapeutics
CARM
$16.6M
| $119K | ﹤0.01% |
1,283
+75
| +6% | +$6.96K |
|
2555
Atossa Therapeutics
ATOS
$106M
| $117K | ﹤0.01% |
18,468
+7,421
| +67% | +$47K |
|
2556
Peabody Energy
BTU
$2.24B
| $114K | ﹤0.01% |
14,405
-591
| -4% | -$4.68K |
|
2557
Arq
ARQ
$298M
| $114K | ﹤0.01% |
15,397
+5,117
| +50% | +$37.9K |
|
|
ALSK
2558
DELISTED
Alaska Communications Systems
ALSK
| $113K | ﹤0.01% |
33,864
+15,994
| +90% | +$53.4K |
|
|
ASXC
2559
DELISTED
Asensus Surgical, Inc.
ASXC
| $112K | ﹤0.01% |
35,275
-1,001
| -3% | -$3.18K |
|
2560
Stoneridge
SRI
$228M
| $111K | ﹤0.01% |
3,760
| – | – |
|
2561
Barings BDC
BBDC
$992M
| $109K | ﹤0.01% |
10,293
-317
| -3% | -$3.36K |
|
2562
Harvard Bioscience
HBIO
$20.5M
| $109K | ﹤0.01% |
13,112
-12,888
| -50% | -$107K |
|
|
XXII
2563
22nd Century Group
XXII
$6.39M
| – | – |
0
| – | -$68K |
|
|
CYBE
2564
DELISTED
Cyberoptics Corp
CYBE
| $109K | ﹤0.01% |
2,672
+32
| +1% | +$1.31K |
|
2565
Co-Diagnostics
CODX
$12M
| $104K | ﹤0.01% |
+12,658
| New | +$104K |
|
2566
Korro Bio
KRRO
$322M
| $104K | ﹤0.01% |
209
-11
| -5% | -$5.47K |
|
2567
Stereotaxis
STXS
$259M
| $104K | ﹤0.01% |
10,744
-270
| -2% | -$2.61K |
|
2568
Verastem
VSTM
$592M
| $103K | ﹤0.01% |
2,099
-39
| -2% | -$1.91K |
|
2569
Harrow
HROW
$1.48B
| $102K | ﹤0.01% |
10,929
+569
| +5% | +$5.31K |
|
2570
Precigen
PGEN
$1.19B
| $102K | ﹤0.01% |
15,612
+153
| +1% | +$1K |
|
2571
Kopin
KOPN
$355M
| $101K | ﹤0.01% |
12,370
-85
| -0.7% | -$694 |
|
2572
Nature's Sunshine
NATR
$299M
| $100K | ﹤0.01% |
+5,760
| New | +$100K |
|
2573
Utah Medical Products
UTMD
$198M
| $100K | ﹤0.01% |
1,180
| – | – |
|
2574
Ardelyx
ARDX
$1.57B
| $96K | ﹤0.01% |
12,599
-62
| -0.5% | -$472 |
|
2575
Genasys
GNSS
$93M
| $96K | ﹤0.01% |
17,500
-1,100
| -6% | -$6.03K |
|